CN110433114A - The plant extracts inhibited tyrosinase activity and its application - Google Patents

The plant extracts inhibited tyrosinase activity and its application Download PDF

Info

Publication number
CN110433114A
CN110433114A CN201910759872.9A CN201910759872A CN110433114A CN 110433114 A CN110433114 A CN 110433114A CN 201910759872 A CN201910759872 A CN 201910759872A CN 110433114 A CN110433114 A CN 110433114A
Authority
CN
China
Prior art keywords
extract
plant extracts
tyrosinase activity
pyracantha
inhibited tyrosinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910759872.9A
Other languages
Chinese (zh)
Other versions
CN110433114B (en
Inventor
陈小明
李湘玉
贺靖
刘艳芳
蒋丽林
何福林
吕敬崑
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hunan University of Science and Engineering
Original Assignee
Hunan University of Science and Engineering
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunan University of Science and Engineering filed Critical Hunan University of Science and Engineering
Priority to CN201910759872.9A priority Critical patent/CN110433114B/en
Publication of CN110433114A publication Critical patent/CN110433114A/en
Application granted granted Critical
Publication of CN110433114B publication Critical patent/CN110433114B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9771Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

The invention discloses a kind of plant extracts inhibited tyrosinase activity and its applications.The plant extracts is ginkgo biloba extract, pomegranate rind extract, Pyracantha extract, Angelica Dahurica extract, small japanese bearbind extract.Plant extracts single dose prepared by the present invention all has the effect for inhibiting B16 cell in melanoma cells, wherein, it was found that ginkgo biloba extract and pomegranate rind extract and Pyracantha extract and small japanese bearbind extract are used in mixed way, it has obvious synergistic function, can be used as the active raw material for preparing skin-lightening cosmetic.

Description

The plant extracts inhibited tyrosinase activity and its application
Technical field
The invention belongs to technical field of cosmetic preparation, and in particular to a kind of plant extracts inhibited tyrosinase activity And its application.
Background technique
The color of human skin depends on the content and distribution of melanin, and the physiology course that melanin is formed substantially can be general Include as 3 stages: melanocyte generates melanin;Melanin granule passes through melanocyte dendritic processes to epithelial cells Transfer;The melanin granule for being transferred to epithelial cells goes upward to cuticula with epidermal cell, and falls off and drain with cuticula.
Tyrosinase is the key enzyme of organism synthesis of melanin, and the main function of common skin-lightening cosmetic is to influence The metabolism of tyrosinase, melanocyte and melanin.It has now been found that, various plants extract contains inhibition tyrosinase Active substance, such as pitaya fruit, herba stellariae mediae, Stenoloma chusana, stringy stonecrop, humulus grass aerial part, big green handle mulberry, Chinese gall insect gall, setose thistle Herb, black rice chaff, active material are proved to effectively have arbutin, glutathione, chitooligosaccharide-, and oxidized resveratrol etc. removes Other than arbutin is significant in efficacy, other several known bioactive molecule effects are poor, and the arbutin yield of industrialized production Low, side reaction is more, generates the chemical substance unfavorable to human body.
In vivo, the small molecule metabolites complex inhibited tyrosinase activity, often there are many conformations, different The small molecule active of conformation is different, and the active small molecular that most of plant extracts contains is indefinite, and activity is lower, combines several Mutual antagonism often occurs for kind existing plant extracts, and activity is lower, finds and inhibits tyrosinase activity high plant and mention Object or several plant extracts being mutually improved are taken, is the difficult point studied in the art.
Summary of the invention
The purpose of the present invention is to provide a kind of plant extracts inhibited tyrosinase activity.
The present invention also aims to the synergistic plant extracts combination of energy is chosen from above-mentioned plant extracts.
A kind of plant extracts inhibited tyrosinase activity, the plant extracts is ginkgo biloba extract, granatum mentions Take object, Pyracantha extract, Angelica Dahurica extract, small japanese bearbind extract.
The plant extracts is the mixture that ginkgo biloba extract and pomegranate rind extract are mixed according to the mass ratio of 1:1.
The plant extracts is the mixture that Pyracantha extract and small japanese bearbind extract are mixed according to the mass ratio of 1:1.
The extracting method of the ginkgo biloba extract are as follows: choose dry ginkgo leaf, crush, cross 80-120 mesh, 5-8 is added 70% alcohol reflux again extracts 3 times, merging filtrate, and vacuum distillation recycling ethyl alcohol, residual filtrate crosses large pore resin absorption column color Spectrum collects 75% ethanol elution part, is dried under reduced pressure, is made.
The extracting method of the pomegranate rind extract are as follows: choose dry granatum, crush, cross 60-80 mesh, 6- is added 9 times of 70% alcohol reflux extracts 3 times, merging filtrate, and vacuum distillation recycling ethyl alcohol, residual filtrate crosses large pore resin absorption column color Spectrum collects 75% ethanol elution part, is dried under reduced pressure, is made.
The extracting method of the Pyracantha extract are as follows: pyracantha fortuneana dry fruit is crushed, is sieved, 30-60 mesh pyracantha fortuneana powder is made; The ratio that water and ethyl alcohol volume ratio are 3:6 prepares extracting solution;In gram, extracting solution is in terms of milliliter, by solid for correct amount angelica dahurica powder Pyracantha fortuneana powder is soaked in extracting solution 48 hours by liquor ratio 1:8 in terms of grams per milliliter;Refluxing extraction 1 hour, stopping was extracted wait cool down Heat up extraction 1 time again after to room temperature, and Extracting temperature is no more than 80 DEG C;It is filtered by vacuum after cooling, filtrate will be molten with Rotary Evaporators Agent obtains Pyracantha extract after steaming.
The extracting method of the Angelica Dahurica extract are as follows: root of Dahurain angelica dry root is crushed, is sieved, 20-40 mesh angelica dahurica powder is made;Water With the ratio preparation extracting solution that ethyl alcohol volume ratio is 3:7;In gram, extracting solution is in terms of milliliter, by solid-liquid for correct amount angelica dahurica powder Than the 1:10 in terms of grams per milliliter, angelica dahurica powder is soaked in extracting solution 24 hours;Refluxing extraction 1 hour, stopping was extracted wait be cooled to Heat up extraction 1 time again after room temperature, and Extracting temperature is no more than 80 DEG C;It is filtered by vacuum after cooling, filtrate is with Rotary Evaporators by solvent Angelica Dahurica extract is obtained after steaming.
The extracting method of the small japanese bearbind extract are as follows: dry small japanese bearbind cauline leaf is chosen, is crushed, 80-100 mesh is crossed, 5-8 times of 70% alcohol reflux is added to extract 3 times, merging filtrate, vacuum distillation recycling ethyl alcohol, residual filtrate crosses macroporous absorption tree Rouge column chromatography collects 75% ethanol elution part, is dried under reduced pressure, is made.
A kind of face cream includes above-mentioned plant extracts.
The face cream the preparation method is as follows:
(1) plant extracts 5-8g accurately is weighed, be put into beaker;
(2) it measures 100ml distilled water to pour into beaker, is put into magnetite, 1.5h is dissolved by heating in magnetic stirring apparatus;
(3) it after the completion of dissolving by heating, first filters once, rear filtering is primary, obtains plant extracts clarified solution;
(4) another clean beaker is taken, 20ml plant extracts clarified solution is measured with graduated cylinder and pours into beaker, add 200ml Distilled water, stirring;
(5) 4g emulsifier, 2g glycerol are weighed, 10ml dipropylene glycol is measured and pours into beaker together, stir 5min;
(6) 100uL PCA-Na, 10uL essence are instilled, 5min is stirred;
(7) it packs.
Beneficial effects of the present invention: ginkgo biloba extract prepared by the present invention, pomegranate rind extract, Pyracantha extract, the root of Dahurain angelica Extract and small japanese bearbind extract, single dose all have the effect for inhibiting B16 cell in melanoma cells, wherein discovery silver Apricot extract and pomegranate rind extract and Pyracantha extract and small japanese bearbind extract are used in mixed way, and are had apparent synergistic Effect, can be used as the active raw material for preparing skin-lightening cosmetic.
Specific embodiment
The present invention will be further described combined with specific embodiments below.
Plant extracts is prepared with the following method in following embodiments:
The extracting method of ginkgo biloba extract: choosing dry ginkgo leaf, crushes, sieves with 100 mesh sieve, and 6 times of 70% second is added Alcohol reflux extracts 3 times, merging filtrate, and vacuum distillation recycling ethyl alcohol, residual filtrate crosses macroporous absorbent resin column chromatography, collects 75% Ethanol elution part, is dried under reduced pressure, and is made.
The extracting method of pomegranate rind extract: choosing dry granatum, crushes, and crosses 70 meshes, and 8 times of 70% second is added Alcohol reflux extracts 3 times, merging filtrate, and vacuum distillation recycling ethyl alcohol, residual filtrate crosses macroporous absorbent resin column chromatography, collects 75% Ethanol elution part, is dried under reduced pressure, and is made.
The extracting method of Pyracantha extract: pyracantha fortuneana dry fruit is crushed, and 40 mesh pyracantha fortuneana powder are made in sieving;Water and ethyl alcohol The ratio that volume ratio is 3:6 prepares extracting solution;Correct amount angelica dahurica powder in gram, extracting solution in terms of milliliter, by solid-to-liquid ratio with gram/ Milliliter meter 1:8, pyracantha fortuneana powder is soaked in extracting solution 48 hours;Refluxing extraction 1 hour, stopping was extracted after being cooled to room temperature again Heating is extracted 1 time, and Extracting temperature is no more than 80 DEG C;It is filtered by vacuum after cooling, filtrate obtains after being steamed solvent with Rotary Evaporators To Pyracantha extract.
The extracting method of Angelica Dahurica extract: root of Dahurain angelica dry root is crushed, and 30 mesh angelica dahurica powders are made in sieving;Water and ethyl alcohol body Product prepares extracting solution than the ratio for being 3:7;Correct amount angelica dahurica powder in gram, extracting solution in terms of milliliter, by solid-to-liquid ratio with gram/milli Meter 1:10 is risen, angelica dahurica powder is soaked in extracting solution 24 hours;Refluxing extraction 1 hour, stopping was extracted after being cooled to room temperature again Heating is extracted 1 time, and Extracting temperature is no more than 80 DEG C;It is filtered by vacuum after cooling, filtrate obtains after being steamed solvent with Rotary Evaporators To Angelica Dahurica extract.
The extracting method of small japanese bearbind extract: choosing dry small japanese bearbind cauline leaf, crushes, sieves with 100 mesh sieve, and is added 6 times 70% alcohol reflux extracts 3 times, merging filtrate, and vacuum distillation recycling ethyl alcohol, residual filtrate is crossed macroporous absorbent resin column chromatography, received Collect 75% ethanol elution part, is dried under reduced pressure, is made.
Agents useful for same and instrument in following embodiments:
Arbutin (sigma company);B16 mouse black-in tumor cell is purchased from Chinese Academy of Sciences Shanghai Institute of Cell Biology;
RPMI-1640 fluid nutrient medium (containing HEPES, dual anti-), 4 DEG C of refrigerators save;96 well culture plates, 24 well culture plates, 6 Well culture plate;Tally;The sterile filter of 0.20 μ, cryopreservation tube, EP pipe;Pipette;Sample loading gun (Thermo);Centrifuge tube;Oscillation is mixed Close instrument;Microplate reader;Homogenizer;Table-type high-speed refrigerated centrifuge (ShangHai City centrifugal Machine Institute);Electronic scale;Water bath with thermostatic control Case;Cell counter;Visible spectrophotometer (ShangHai City centrifugal Machine Institute).
Influence of 1 plant extracts of embodiment to Melanoma Cell Proliferation
Each plant extracts sample is diluted to the dense of 6.25,12.5,25,50,100 μ g/mL with fluid nutrient medium respectively Degree, and with 0.20 μm of sterile filter filter after it is spare.
The B16 mouse black-in tumor cell for selecting logarithmic growth phase, it is complete with RPMI-1640 after the digestion of 0.25% pancreatin It is 1 × 10 that culture medium, which is made into density,5A cell suspension is inoculated in 96 well culture plates, every 100 μ L of hole, in 37 DEG C, 5%CO2Training Support culture in case.After adherent, it is separately added into the complete culture solution of the sample containing various concentration, control group adds isometric cell outstanding Liquid, and set blank control group and add isometric complete medium, every 100 μ L of hole.Each concentration sets 3 multiple holes, 37 DEG C, 5%CO2 In incubator after culture 72h, mtt assay measures absorbance (OD) value at microplate reader 570nm.It is opposite that cell is calculated according to the following formula Proliferation rate:
Cell opposite proliferation rate=[(A-C)/(B-C)] × 100%
Wherein A is each concentration mean absorbance values of object to be sieved, and B is control group mean absorbance values, and C is that blank group is averagely inhaled Shading value.Test result is shown in Table 1:
Opposite proliferation rate of 15 Plant Extracts of table to melanoma cells
As can be seen from Table 1, as the arbutin of positive control when dosage is 100 μ g/mL, to the phase of melanoma cells It is 85.31% to proliferation rate, ginkgo biloba extract faint to B16 mouse black-in tumor cell toxicity, pomegranate rind extract, pyracantha fortuneana mentions Take object, Angelica Dahurica extract, small japanese bearbind extract is fainter to B16 mouse black-in tumor cell toxicity.
B16 melanoma cells strain is a kind of gland cell with dendrite, since dendrite is that melanoma cells are defeated The channel of melanin granule is sent, while being also the bridge contacted with keratinocyte, therefore, the upgrowth situation of melanoma cells Whether normal, the performance of melanoma cells function plays a significant role.This experiment confirms plant extracts of the invention to B16 Melanoma cells toxic effect is very small, also further illustrates to cell fanout free region for normal somatic cell also just there are no evil, Plant extracts of the invention is not to block B16 cell in melanoma cells, Jin Erda by inhibiting cel l proliferation Arrive whitening effect.
Influence of 2 plant extracts of embodiment to B16 cell in melanoma cells
By the 3rd generation melanoma cells of culture with 1 × 104A density connects hole in 6 orifice plates, changes liquid afterwards for 24 hours.Add test sample 3 holes of every kind of drug of product, sample concentration is the same as embodiment 1.Control group replaces sample solution with RPMI1640 culture solution.37 DEG C, 5% CO272h after incubation, discards supernatant liquid.Every hole is added 2.5g/L pancreatin and digests 5min at room temperature.4mL culture solution is added to stop Digestion, and blow and beat into single cell suspension.0.5mL is taken to make cell count, remaining cell suspension 1500r/min is centrifuged 10min, in abandoning Clearly, the NaOH of 1mL1mol/L is added, and surveys its absorbance value at microplate reader 490nm after incubation 2h in 90 DEG C of water-baths.It presses Following equation calculates B16 cell amount and drug to the inhibiting rate of B16 cell.
Melanin genesis inhibiting rate=[1- (sample well absorbance value/sample well cell density)/(control wells absorbance value/right According to hole cell density) × 100%, test result is shown in Table 2:
Inhibiting effect of 25 Plant Extracts of table to melanoma cells B16 cell
As can be seen from Table 2, arbutin, pomegranate rind extract, small japanese bearbind extract close B16 melanoma cells melanin At inhibiting effect it is apparent that sample concentration be 100 μ g/mL when, the inhibiting rate of B16 cell is respectively reached 33.48%, 30.82% and 38.92%, ginkgo biloba extract, Pyracantha extract, Angelica Dahurica extract is also inhibited, but presses down It is weaker to make use.
It chooses above-mentioned plant extracts to mix two-by-two, concentration is 50 μ g/mL, repeats above-mentioned melanoma cells melanin and closes At Inhibition test, experimental result is shown in Table 3:
Inhibiting effect of the 3 mixed plant extract of table to melanoma cells B16 cell
As can be seen from Table 3, most of mixed plant extract weakens with respect to the inhibiting effect of single dose, is in antagonism, Ginkgo biloba extract and pomegranate rind extract are applied in combination, and Pyracantha extract and small japanese bearbind extract combination use, and inhibiting effect increases By force, synergy is shown as.
It is well known that tyrosinase is the key enzyme of synthesis of melanin in organism, the metalloenzyme of this cupric can be urged Change single phenol hydroxylation to be oxidized to quinone (o-diphenolase activity) at diphenol (single phenol enzymatic activity), and diphenol, quinone shape under the conditions of non-enzymatic At final reaction product melanin, it is mutual by influencing tyrosinase, dopachrome that plant extracts, which inhibits B16 cell, Become the expression and activity or other mechanism not understood for us of enzyme and dihydroxy indole carboxylic oxidase etc., finally Achieve the purpose that skin whitening.
Embodiment 3
Face cream, preparation method are as follows:
(1) ginkgo biloba extract 3g accurately is weighed, pomegranate rind extract 3g is put into beaker;
(2) it measures 100ml distilled water to pour into beaker, is put into magnetite, 1.5h is dissolved by heating in magnetic stirring apparatus;
(3) it after the completion of dissolving by heating, first filters once, rear filtering is primary, obtains plant extracts clarified solution;
(4) another clean beaker is taken, 20ml plant extracts clarified solution is measured with graduated cylinder and pours into beaker, add 200ml Distilled water, stirring;
(5) 4g emulsifier, 2g glycerol are weighed, 10ml dipropylene glycol is measured and pours into beaker together, stir 5min;
(6) 100uL PCA-Na, 10uL essence are instilled, 5min is stirred;
(7) it packs.
Embodiment 4
Face cream, preparation method are as follows:
(1) Pyracantha extract 3g accurately is weighed, small japanese bearbind extract 3g is put into beaker;
(2) it measures 100ml distilled water to pour into beaker, is put into magnetite, 1.5h is dissolved by heating in magnetic stirring apparatus;
(3) it after the completion of dissolving by heating, first filters once, rear filtering is primary, obtains plant extracts clarified solution;
(4) another clean beaker is taken, 20ml plant extracts clarified solution is measured with graduated cylinder and pours into beaker, add 200ml Distilled water, stirring;
(5) 4g emulsifier, 2g glycerol are weighed, 10ml dipropylene glycol is measured and pours into beaker together, stir 5min;
(6) 100uL PCA-Na, 10uL essence are instilled, 5min is stirred;
(7) it packs.

Claims (10)

1. a kind of plant extracts inhibited tyrosinase activity, which is characterized in that the plant extracts be ginkgo biloba extract, Pomegranate rind extract, Pyracantha extract, Angelica Dahurica extract, small japanese bearbind extract.
2. the plant extracts inhibited tyrosinase activity according to claim 1, which is characterized in that the plant extracts The mixture mixed for ginkgo biloba extract and pomegranate rind extract according to the mass ratio of 1:1.
3. the plant extracts inhibited tyrosinase activity according to claim 1, which is characterized in that the plant extracts The mixture mixed for Pyracantha extract and small japanese bearbind extract according to the mass ratio of 1:1.
4. the plant extracts inhibited tyrosinase activity according to claim 1, which is characterized in that the ginkgo biloba extract Extracting method are as follows: choose dry ginkgo leaf, crush, cross 80-120 mesh, be added 5-8 times 70% alcohol reflux extraction 3 Secondary, ethyl alcohol is recycled in merging filtrate, vacuum distillation, and residual filtrate crosses macroporous absorbent resin column chromatography, collects 75% ethanol elution portion Point, it is dried under reduced pressure, is made.
5. the plant extracts inhibited tyrosinase activity according to claim 1, which is characterized in that the granatum extracts The extracting method of object are as follows: choose dry granatum, crush, cross 60-80 mesh, 6-9 times of 70% alcohol reflux is added and extracts 3 Secondary, ethyl alcohol is recycled in merging filtrate, vacuum distillation, and residual filtrate crosses macroporous absorbent resin column chromatography, collects 75% ethanol elution portion Point, it is dried under reduced pressure, is made.
6. the plant extracts inhibited tyrosinase activity according to claim 1, which is characterized in that the Pyracantha extract Extracting method are as follows: pyracantha fortuneana dry fruit is crushed, be sieved, 30-60 mesh pyracantha fortuneana powder is made;Water and ethyl alcohol volume ratio are 3:6's Ratio prepares extracting solution;In gram, extracting solution, will by solid-to-liquid ratio 1:8 in terms of grams per milliliter in terms of milliliter for correct amount angelica dahurica powder Pyracantha fortuneana powder is soaked in extracting solution 48 hours;Refluxing extraction 1 hour, the extraction 1 time that heats up again after being cooled to room temperature was extracted in stopping, Extracting temperature is no more than 80 DEG C;It is filtered by vacuum after cooling, filtrate obtains Pyracantha extract after being steamed solvent with Rotary Evaporators.
7. the plant extracts inhibited tyrosinase activity according to claim 1, which is characterized in that the Angelica Dahurica extract Extracting method are as follows: root of Dahurain angelica dry root is crushed, be sieved, 20-40 mesh angelica dahurica powder is made;The ratio that water and ethyl alcohol volume ratio are 3:7 Example preparation extracting solution;In gram, extracting solution, will be white by solid-to-liquid ratio 1:10 in terms of grams per milliliter in terms of milliliter for correct amount angelica dahurica powder Root of Dahurian angelica powder is soaked in extracting solution 24 hours;Refluxing extraction 1 hour, the extraction 1 time that heats up again after being cooled to room temperature was extracted in stopping, being mentioned Temperature is taken to be no more than 80 DEG C;It is filtered by vacuum after cooling, filtrate obtains Angelica Dahurica extract after being steamed solvent with Rotary Evaporators.
8. the plant extracts inhibited tyrosinase activity according to claim 1, which is characterized in that the small japanese bearbind extracts The extracting method of object are as follows: choose dry small japanese bearbind cauline leaf, crush, cross 80-100 mesh, 5-8 times of 70% alcohol reflux is added It extracts 3 times, merging filtrate, vacuum distillation recycling ethyl alcohol, residual filtrate crosses macroporous absorbent resin column chromatography, collects 75% ethyl alcohol and washes De- part, is dried under reduced pressure, is made.
9. a kind of face cream, which is characterized in that include plant extracts described in claim 1.
10. face cream according to claim 9, which is characterized in that the face cream the preparation method is as follows:
(1) plant extracts 5-8g accurately is weighed, be put into beaker;
(2) it measures 100ml distilled water to pour into beaker, is put into magnetite, 1.5h is dissolved by heating in magnetic stirring apparatus;
(3) it after the completion of dissolving by heating, first filters once, rear filtering is primary, obtains plant extracts clarified solution;
(4) another clean beaker is taken, 20ml plant extracts clarified solution is measured with graduated cylinder and pours into beaker, adds 200ml distillation Water, stirring;
(5) 4g emulsifier, 2g glycerol are weighed, 10ml dipropylene glycol is measured and pours into beaker together, stir 5min;
(6) 100uL PCA-Na, 10uL essence are instilled, 5min is stirred;
(7) it packs.
CN201910759872.9A 2019-08-16 2019-08-16 Plant extract for inhibiting tyrosinase activity and application thereof Active CN110433114B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910759872.9A CN110433114B (en) 2019-08-16 2019-08-16 Plant extract for inhibiting tyrosinase activity and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910759872.9A CN110433114B (en) 2019-08-16 2019-08-16 Plant extract for inhibiting tyrosinase activity and application thereof

Publications (2)

Publication Number Publication Date
CN110433114A true CN110433114A (en) 2019-11-12
CN110433114B CN110433114B (en) 2022-03-22

Family

ID=68436117

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910759872.9A Active CN110433114B (en) 2019-08-16 2019-08-16 Plant extract for inhibiting tyrosinase activity and application thereof

Country Status (1)

Country Link
CN (1) CN110433114B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111388367A (en) * 2020-03-25 2020-07-10 江南大学 Composition for inhibiting melanin at multiple target points, preparation method and application of composition in cosmetics
CN113318061A (en) * 2021-06-16 2021-08-31 上海南滨江细胞生物科技有限公司 A facial cream containing embryo extract and its preparation method
CN113476356A (en) * 2021-04-30 2021-10-08 云南英格生物技术有限公司 Preparation method and application of pyracantha fortuneana fruit extract

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07238011A (en) * 1994-02-24 1995-09-12 Suntory Ltd Skin-beautifying cosmetic composition
WO2009067095A1 (en) * 2007-11-19 2009-05-28 Stiefel Laboratories, Inc. Topical cosmetic skin lightening compositions and methods of use thereof
CN103251659A (en) * 2013-06-03 2013-08-21 青岛三九九洲生物技术有限公司 Preparation method of ginkgo leaf essence
CN105434201A (en) * 2014-09-25 2016-03-30 伽蓝(集团)股份有限公司 Composition containing pomegranate extract and use thereof, and skin externally-applied agent
CN107384069A (en) * 2017-06-30 2017-11-24 天长市巨龙车船涂料有限公司 A kind of waterborne UV coating
CN109125150A (en) * 2017-06-15 2019-01-04 新乡医学院三全学院 A kind of skin care item and the preparation method and application thereof containing hawthorne leaf P.E

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07238011A (en) * 1994-02-24 1995-09-12 Suntory Ltd Skin-beautifying cosmetic composition
WO2009067095A1 (en) * 2007-11-19 2009-05-28 Stiefel Laboratories, Inc. Topical cosmetic skin lightening compositions and methods of use thereof
CN101917965A (en) * 2007-11-19 2010-12-15 施泰福实验室股份有限公司 Topical cosmetic skin lightening compositions and methods of use thereof
CN103251659A (en) * 2013-06-03 2013-08-21 青岛三九九洲生物技术有限公司 Preparation method of ginkgo leaf essence
CN105434201A (en) * 2014-09-25 2016-03-30 伽蓝(集团)股份有限公司 Composition containing pomegranate extract and use thereof, and skin externally-applied agent
CN109125150A (en) * 2017-06-15 2019-01-04 新乡医学院三全学院 A kind of skin care item and the preparation method and application thereof containing hawthorne leaf P.E
CN107384069A (en) * 2017-06-30 2017-11-24 天长市巨龙车船涂料有限公司 A kind of waterborne UV coating

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
何蓉蓉等: "火棘果实提取物的美白作用", 《中国实验方剂学杂志》 *
罗达尚,: "《晶珠本草正本诠释》", 11 September 1995, 四川科学技术出版社 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111388367A (en) * 2020-03-25 2020-07-10 江南大学 Composition for inhibiting melanin at multiple target points, preparation method and application of composition in cosmetics
CN113476356A (en) * 2021-04-30 2021-10-08 云南英格生物技术有限公司 Preparation method and application of pyracantha fortuneana fruit extract
CN113318061A (en) * 2021-06-16 2021-08-31 上海南滨江细胞生物科技有限公司 A facial cream containing embryo extract and its preparation method

Also Published As

Publication number Publication date
CN110433114B (en) 2022-03-22

Similar Documents

Publication Publication Date Title
CN110433114A (en) The plant extracts inhibited tyrosinase activity and its application
CN100391495C (en) Process for extracting litchi polyphenol from litchi
CN104546980B (en) A kind of bee pollen extract and its preparation and application
CN106266587B (en) Orchid extract and its preparation method and application
Li et al. Optimization of enzyme assisted extraction of polysaccharides from pomegranate peel by response surface methodology and their anti-oxidant potential
CN104688801B (en) A kind of complex enzyme combination ultrasound extracts the production technology of eucommia bark flavone from folium cortex eucommiae
CN110201012A (en) A kind of Preparation method and use of purslane extract
CN104983915B (en) A kind of preparation method of black fruit fructus lycii natural composite antioxidant
CN108530430A (en) Ester catechin pyrrolidine alkaloid and its preparation method and application
CN103815279B (en) Red yeast rice rich in coenzyme Q10 and preparation method thereof
CN104610054B (en) Caffeoyl hydroquinone ester and preparation method and application of caffeoyl hydroquinone ester in preparation of tyrosinase inhibitor
Jiang et al. Protective effect of blood cora polysaccharides on H9c2 rat heart cells injury induced by oxidative stress by activating Nrf2/HO-1 signal pathway
CN108315361A (en) A method of utilizing Microbe synthesis parahydroxyben-zaldehyde
CN106924117B (en) With the washing product composition of artemisia annua residue preparation remaining after extraction qinghaosu
CN107353273B (en) The method of luteolin and Rubus corchorifolius element is extracted from Rubus corchorifolius
Piao et al. Cell suspension culture of Orostachys cartilaginous in bioreactor systems for bioactive compound production and evaluation of their antioxidant properties
US20220370538A1 (en) Method for extracting functional ingredients of mulberry leaves using enzymes
CN109010201A (en) A kind of preparation method and application of almond ringdove chrysanthemum saponin(e
CN105200112B (en) A kind of preparation method of Armillaria luteo-virens fructification resisting liver cancer activity sterols component
CN109929006B (en) Extraction method and application of ergosterol peroxide in pleurotus ferulae
CN102344470A (en) Method for extracting wild persimmon leaf tannin by ultrasonic wave auxiliary semi-bionic method
CN104127509B (en) A kind of aqueous enzymatic method-semi-biomimetic method extracts the method for general anthraquinone in Rhizoma Polygoni Cuspidati
CN108125946A (en) Application of the dihydromyricetin in terms of kidney medicine is prepared
CN107028842B (en) Extraction method of active site of rose dregs and application thereof
JP6741965B2 (en) Dehydroretinol derivative exhibiting keratin increasing action

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant